Please use this identifier to cite or link to this item:
Title: Penicillin Allergy Impact and Management.
Austin Authors: Wrenn, Rebekah H;Trubiano, Jason 
Affiliation: Duke University Medical Center, Durham, NC, USA; Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC, USA.
Infectious Diseases
Department of Infectious Diseases, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Victoria 3000, Australia; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Centre for Antibiotic Allergy and Research
Issue Date: 1-Aug-2023
Date: 2023
Publication information: Infectious Disease Clinics of North America 2023-08-01
Abstract: There is international evidence that penicillin allergies are associated with inferior prescribing and patient outcomes. A host of tools now exist from assessment (risk assessment tools, clinical decision rules) to delabeling (the removal of a beta-lactam allergy via testing or medical reconciliation) to reduce the impact of these "labels" in the hospital and community setting, as a primary antimicrobial stewardship intervention.
DOI: 10.1016/j.idc.2023.06.005
Journal: Infectious Disease Clinics of North America
PubMed URL: 37537003
ISSN: 1557-9824
Type: Journal Article
Subjects: Delabeling
Drug allergy
Oral challenge
Penicillin allergy
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on May 28, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.